Search results
Results from the WOW.Com Content Network
In April 2021, the Indian Council of Medical Research reported that the vaccine has shown promising results in neutralising lineage B.1.617. [ 54 ] [ 55 ] In May 2021, a joint investigation by the scientists of the National Institute of Virology , found the vaccine effective in neutralising the Zeta variant or lineage P.2 (previously known as B ...
On 21 October 2021, according to the CoWIN portal, India crossed 1 billion doses. [20] From 3 January 2022, eligibility was extended for the citizens above 15 years of age, for which registration started from 1 January 2022, on CoWIN. Currently Covaxin, Corbevax, Covovax vaccine is approved for 15-18 age group. [21] [22]
COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021. India began its vaccination programme on 16 January 2021, operating 3,006 vaccination centres on the onset. [23] Each vaccination centre will offer either Covishield or Covaxin, but not both. [24] 165,714 people were vaccinated on the first day of availability.
On 15 April 2021, Delhi Chief Minister Arvind Kejriwal announced a weekend curfew along with tight restrictions on weekdays in order to curb the second wave of COVID-19 infections. On 17 April 2022, Delhi saw a rise in cases, but the positivity rate has relatively reduced from 5.33% to 4.21% [ 22 ]
COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021. Vaccination in India includes the use of vaccines in Indian public health and the place of vaccines in Indian society, policy, and research.
On 30 April 2021, it became the first country to report over 400,000 new cases in a 24-hour period. [ 15 ] [ 6 ] Experts stated that the virus may reach an endemic stage in India rather than completely disappear; [ 16 ] in late August 2021, Soumya Swaminathan said India may be in some stage of endemicity where the country learns to live with ...
Mission Indradhanush is a health mission of the Government of India.It was launched by Union Health Minister J. P. Nadda on 25 December 2014. [1] The scheme this seeks to drive towards 90% full immunisation coverage of India and sustain the same by year 2022.
Review of Vaccine Adverse Events Reporting System (VAERS) safety monitoring data by the US Centers for Disease Control and Prevention (CDC) through 21 April 2021, (by which time 7.98 million doses of the Janssen COVID‑19 vaccine had been administered), showed that "97% of reported reactions after vaccine receipt were nonserious, consistent ...